edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

US Administration Scrutiny on Chinese Pharma R&D Raises Market Concerns
Stock NewsThemesUS Administration Scrutiny on Chinese Pharma R&D Raises Market Concerns

US Administration Scrutiny on Chinese Pharma R&D Raises Market Concerns

Edgen StockEdgen Stock·Sep 14 2025, 00:52
Share to
Share to
Copy link
AZNAZN+1.91%BMYBMY+1.73%LLYLLY+1.43%GSKGSK+0.71%
US Administration Scrutiny on Chinese Pharma R&D Raises Market Concerns
source:
[1] China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington (https://www.thedailyupside.com/industries/hea ...)[2] "A single regulatory decree cannot hinder industry trends; many institutions remain optimistic about the development of innovative pharmaceuticals." - Moomoo (https://vertexaisearch.cloud.google.com/groun ...)[3] 48 billion dollars in half a year! How is China reshaping the global pharmaceutical landscape behind record-breaking trade deals? (https://vertexaisearch.cloud.google.com/groun ...)

Related News

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live
Dec 21 2025, 11:28

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

BlackSky Technology (BKSY) stock has gained 80.07% year-to-date after the successful deployment of its third Gen-3 satellite, which became commercially active three weeks after launch.

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls
Dec 21 2025, 07:04

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

Google's dual-track AI strategy is validated as OpenAI's focus on complex models leads to a user growth bottleneck despite revenues surpassing $19 billion.

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets
Dec 21 2025, 06:44

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets

A CITIC Securities report highlights that China's record $1.076 trillion trade surplus is driving expectations for a sustained RMB appreciation, which is expected to boost profits for import-reliant industries.